<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04375618</url>
  </required_header>
  <id_info>
    <org_study_id>SVSIDS/perio/5/2019</org_study_id>
    <nct_id>NCT04375618</nct_id>
  </id_info>
  <brief_title>RhEGF Incorporated in An Absorbable Collagen Membrane for The Management Of Gingival Recession Defects</brief_title>
  <official_title>Efficacy of Recombinant Human Epidermal Growth Factor (RhEGF) Incorporated in An Absorbable Collagen Membrane for The Management of Gingival Recession Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SVS Institute of Dental Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SVS Institute of Dental Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A sulcular incision will be made through each recession area and the tissues will be
      gradually undermined including the base of the interdental papilla. At the recession sites
      rhEGF incorporated absorbable collagen membrane will be gradually manipulated into the pouch
      through the tunnel till it covers the recession sites and will be stabilized with sutures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      IN TEST SITE :

      Local anesthesia will be administered and Vertical incisions will be given at interdental
      papillae away from recession defect site and a pouch will be created. A sulcular incision
      will be made through each recession area and the tissues will be gradually undermined
      including the base of the interdental papilla. At the recession sites rhEGF incorporated
      absorbable collagen membrane will be gradually manipulated into the pouch through the tunnel
      till it covers the recession sites and will be stabilized with sutures.

      IN CONTROL SITE:

      Same procedure will be done as the test site but plain collagen membrane will be gradually
      manipulated into the pouch through the tunnel till it covers the recession sites and will be
      stabilized with sutures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recession depth (RD)</measure>
    <time_frame>Base line to 6months.</time_frame>
    <description>Recession depth (RD) - measured from cementoenamel junction to most apical extension of gingival margin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Width of keratinized gingiva (KGW)</measure>
    <time_frame>Base line to 6months.</time_frame>
    <description>Width of keratinized gingiva (KGW) - distance between gingival margin and mucogingival junction will be evaluated.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>EGF impregnated in collagen membrane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EGF impregnated in collagen membrane is placed in gingival recession defects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>plain collagen membrane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>plain collagen membrane is placed in gingival recession defects</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>RhEGF</intervention_name>
    <description>The EGF impregnated membrane will be placed upon the recession site and will be stabilized by suturing it to the lingual papillae using 4-0 absorbable sutures. The flap will be coronally advanced as far as possible to cover the membrane and will be sutured to the buccal interdental papillae with 4-0 absorbable sutures (Trulenetm, Healthium Medtech Pvt Ltd, Bangalore, India). Standard recall and maintenance regimen will be followed and subjects will be encouraged to report to the department on a monthly basis.</description>
    <arm_group_label>EGF impregnated in collagen membrane</arm_group_label>
    <other_name>EGF+Collagen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Plain Collagen</intervention_name>
    <description>A collagen membrane without FGF-2 will be used.</description>
    <arm_group_label>plain collagen membrane</arm_group_label>
    <other_name>Control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Systemically healthy male and female patients of age 20-55 yrs with Millers class I or
             class II gingival recession are included in the study.

        Exclusion Criteria:

          -  Patients who are medically compromised and Subjects who underwent radiotherapy or
             chemotherapy and who are Smokers are excluded from the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>R V Chandra, MDS;DNB;PHD</last_name>
    <phone>9908183071</phone>
    <email>viswachandra@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>R V Chandra</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <zip>509002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R V Chandra, MDS;DNB;PhD</last_name>
      <phone>9908183071</phone>
      <email>viswachandra@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 29, 2020</study_first_submitted>
  <study_first_submitted_qc>May 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2020</study_first_posted>
  <last_update_submitted>May 2, 2020</last_update_submitted>
  <last_update_submitted_qc>May 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>SVS Institute of Dental Sciences</investigator_affiliation>
    <investigator_full_name>Dr R Viswa Chandra</investigator_full_name>
    <investigator_title>Primary Investigator</investigator_title>
  </responsible_party>
  <keyword>epidermal growth factor</keyword>
  <keyword>gingival recession</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Gingival Recession</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

